✦ LIBER ✦

Zinc for severe pneumonia in very young children: double-blind placebo-controlled trial

✍ Scribed by W Abdullah Brooks; M Yunus; Mathuram Santosham; MA Wahed; Kamrun Nahar; Sultana Yeasmin; Robert E Black

Book ID: 117286281
Publisher: The Lancet
Year: 2004
Tongue: English
Weight: 96 KB
Volume: 363
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(04)16252-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zinc adjunct therapy reduces case fatali

Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial

✍ Maheswari G Srinivasan; Grace Ndeezi; Cordelia Katureebe Mboijana; Sarah Kiguli; 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 212 KB

The Efficacy of Zinc Supplementation on

The Efficacy of Zinc Supplementation on Outcome of Children with Severe Pneumonia. A Randomized Double-blind Placebo-controlled Clinical Trial

✍ Ehsan Valavi; Mehran Hakimzadeh; Ahmad Shamsizadeh; Majid Aminzadeh; Arash Algha 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 183 KB

Efficacy of zinc given as an adjunct in

Efficacy of zinc given as an adjunct in the treatment of severe and very severe pneumonia in hospitalized children 2-24 mo of age: a randomized, double-blind, placebo-controlled trial

✍ Wadhwa, N.; Chandran, A.; Aneja, S.; Lodha, R.; Kabra, S. K.; Chaturvedi, M. K.; 📂 Article 📅 2013 🏛 American Society for Clinical Nutrition: 🌐 English ⚖ 256 KB

Role of zinc in severe pneumonia: a rand

Role of zinc in severe pneumonia: a randomized double bind placebo controlled study

✍ Gauri S Shah, Ashok K Dutta, Dheeraj Shah, Om P Mishra 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 152 KB

Prophylactic ibuprofen versus placebo in

Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial

✍ V Gournay; JC Roze; A Kuster; P Daoud; G Cambonie; JM Hascoet; C Chamboux; T Bla 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 185 KB

Mepolizumab for severe eosinophilic asth

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

✍ Ian D Pavord; Stephanie Korn; Peter Howarth; Eugene R Bleecker; Roland Buhl; Oli 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 400 KB